Stock FME FRESENIUS MEDICAL CARE AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Fresenius Medical Care AG

Equities

FME

DE0005785802

Market Closed - Xetra
Other stock markets
 11:35:01 2024-04-23 am EDT 		Pre-market 01:57:50 am
39.9 EUR +2.36% Intraday chart for Fresenius Medical Care AG 40.16 +0.64%
Apr. 23 FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Warburg Research reiterates its Sell rating ZD
Apr. 23 FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank gives a Neutral rating ZD

Summary

  • The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The company has a low valuation given the cash flows generated by its activity.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+5.11% 12.53B
A-
CVS HEALTH CORPORATION Stock CVS Health Corporation
-13.25% 86.34B
B-
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+18.01% 84.49B
C+
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+11.97% 29.68B
C+
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-8.50% 17.5B
B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-1.46% 16.67B
A-
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
+4.44% 12.71B
A-
PURE HEALTH HOLDING Stock Pure Health Holding
-31.05% 11.89B - -
DAVITA INC. Stock DaVita Inc.
+27.83% 11.74B
B-
UNIVERSAL HEALTH SERVICES, INC. Stock Universal Health Services, Inc.
+8.18% 11.1B
B-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. FME Stock
  4. Ratings Fresenius Medical Care AG